Our Pharmaceutical Director, Dr Gerry Kenna, recently presented a virtual seminar on “In vitro models for assessment of drug-induced liver injury (DILI): a personal perspective” to the Liver Toxicity Working Group of the US regulator, the FDA
Rebecca Ram was invited to give a presentation on the issues concerning use of animals in research at a recent workshop hosted by Advocates for Animals, the UK’s first legal organisation devoted to animal protection.
Our Research Consultant, Dr Pandora Pound is speaking this afternoon at the 11th World Congress on Alternatives and Animal Use in the Life Sciences, on “Breaking the lock-in to animal research within academia”.
Our Scientific Consultant, Rebecca Ram, spoke at the 11th World Congress on Alternatives and Animal Use in the Life Sciences on “New Approach Methodologies Funding and Regulation”.
In a recent webinar our Director Dr Jan Turner, described why gaps in this data either through selective reporting or omission of significant data all together, can have profound effects on the decision-making of regulatory agencies and ultimately lead to unsafe drugs being placed on the market.
“The future of medicines regulation in the UK” was the subject of a recent Westminster Health Forum meeting at which our Director, Dr Jan Turner described why innovation and the development of methods to ensure safe and effective medicines, is imperative for the UK. See the presentation here.
Presentation by Dr Jan Turner
“The future for UK regulation of medicines, medical devices and clinical trials – transparency and public trust, safety and enforcement, and support for innovation” was the subject of a recent Westminster Health Forum meeting at which our Director, Dr Jan Turner described why innovation and the development of methods to ensure safe and effective medicines, is imperative for the UK now and importantly, post Brexit.
Hosted by the Physicians Committee for Responsible Medicine, in conjunction with US Congresswoman Lucille Roybal-Allard, our Pharmaceutical Director, Dr Gerry Kenna, recently spoke on why “Human-relevant models are needed to understand and treat human COVID-19 disease” at PCRM’s Congressional hearing “Confronting COVID-19: A Briefing on Prioritizing Human-Based Research”. A recording of the event is here and Dr Kenna’s slides are here.
2020: Lecture by Pandora Pound for course: Animals in Research: Law, Policy, and Humane Sciences, at Johns Hopkins Bloomberg School of Public Health, US See details of whole course here and slides for lecture by Pandora Pound here: animals-lec11
Hear our Director Dr Jan Turner speak about barriers and progress to adoption of human relevant in vitro models in drug discovery at the Advances in Cell and Tissue Culture conference in Cardiff, June 2019
See our Pharmaceutical Director, Dr Gerry Kenna, present on the prediction of human hazard using in vitro data at the British Toxicological Society (BTS) Annual Congress, Cambridge UK, 17th April 2019.
Dr Jan Turner speaking at the March 8th 2019 London Conference to launch the book:
Dr Gerry Kenna speaking on: “Overcoming obstacles to human-relevant science.” WIST 2nd Congress: Science instead of animals. Cologne, Germany, October 27, 2018
Dr Bob Coleman, UK Science Director of Safer Medicines Trust, also spoke at the Conference on ‘Humanising Drug Safety Testing’ – view his presentation
15 minute presentation by Dr Bob Coleman at Horizons in Human Cells conference, Edinburgh, May 2014: “Humanising Drug Safety Testing”
4 minute clip from BBC “Bang Goes the Theory” on growing living human brain cells into 3D ‘mini-brains’ to study Alzheimer’s Disease
24 minute presentation by Dr Bob Coleman at American College of Toxicology annual meeting, San Antonio, Texas, 4 November 2013:
Ensuring safety and efficacy in new medicines – humanising the process
Slide presentation by Dr Bob Coleman at Linz University, Austria, 17th September 2013: “Humanising Toxicity Testing in the 21st Century”.
An amazing MUST-SEE short (4 minute) film from Harvard University about their ‘organs-on-a-chip’ from Technology Review, July/August 2012
A 25 minute interview with Safer Medicines’ director, Kathy Archibald, on the “Freedom of Species” (http://www.3cr.org.au/freedomofspecies) radio show from Melbourne, Australia, October 2011
Dr Margaret Clotworthy is interviewed during a feature on the increase in animal experimentation in the UK. Her contribution starts half way through the 9 minute clip available here.
Safer Medicines showcases state-of-the-art approaches to ensuring that drugs in the future will be safer than they have been in the past. World leading scientists from industry and academia present their vision for the future of drug development – with a focus on human biology.
Debate at the London School of Economics and Political Science (LSE), January 16th 2007: Animal Testing: Necessary Cruelty or Cruelly Unnecessary?
YOU CAN LISTEN TO THE SPEAKERS HERE:
Thanks to Aled Fisher, Environment and Ethics Officer, LSE Students’ Union, for organising and chairing the debate.
Interview with Dr Jarrod Bailey, scientific director of Europeans for Medical Progress – With kind permission of Passion for the Planet Radio: www.passionfortheplanet.com
Listen to interview (2005)
By Rebecca Ram This month marks World Liver Day (held every year on 19 Apr) to raise awareness about diseases of the second largest organ in the body. After the brain, the liver is the most complex organ and is vital to the efficient control of the gastrointestinal (digestive) system. Liver diseases account for approximately […]New Approach Methodologies in COVID-19: systematic review into the neurological effects of SARS-CoV-2 infection presented at SOT (Society of Toxicology) Congress 2022
By Rebecca Ram Launched nearly two years ago, the CIAO project (Modelling the Pathogenesis of COVID-19 using the Adverse Outcome Pathway Framework) involves the collaboration of scientific experts to identify the chemical and biological events involved in the body’s response to the SARS-CoV-2 virus. Expert working groups are established across a number of areas, for […]